Prevalence and clinical characteristics of acute myeloid leukemia associated with disseminated intravascular coagulation.

Prevalence and clinical characteristics of acute myeloid leukemia associated with disseminated intravascular coagulation. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Prevalence and clinical characteristics of acute myeloid leukemia associated with disseminated intravascular coagulation. Abstract Text:

Hideki Uchiumi,Takafumi Matsushima,Arito Yamane,Noriko Doki,Hiroyuki Irisawa,Takayuki Saitoh,Tohru Sakura,Takahiro Jimbo,Hiroshi Handa,Norifumi Tsukamoto,Masamitsu Karasawa,Shuichi Miyawaki,Hirokazu Murakami,Yoshihisa Nojima,

Disseminated intravascular coagulation (DIC) is one of the important complications to develop in patients with acute myeloid leukemia (AML). While acute promyelocytic leukemia (APL) is a strong risk factor for DIC, other clinical features have not been fully defined. We retrospectively analyzed 161 consecutive adult patients with de novo non-APL AML. DIC was diagnosed in 52 patients (32%); 28 patients at diagnosis and 24 soon after the initiation of induction chemotherapy. Leukocyte counts, C-reactive protein, and lactate dehydrogenase were significantly higher in the DIC+ group. Negative expressions of CD13, CD19, CD34, and HLA-DR were more prevalent in the DIC+ group. On multivariate logistic-regression analysis, variables that were independently associated with the development of DIC were high C-reactive protein, high leukocyte count, negative expressions of CD13 and HLA-DR, and cytogenetics with a normal karyotype or 11q23 abnormality. Although DIC is considered to be associated with serious morbidity and occasional mortality, we did not find any significant differences in the complete remission rate, overall or disease-free survival between DIC+ and DIC- groups. This study is the first to define the clinical characteristics associated with DIC in patients with non-APL AML, but exactly how and when DIC should be treated remains to be determined.

Prevalence and clinical characteristics of acute myeloid leukemia associated with disseminated intravascular coagulation. Publishing Authors By Initials

H Uchiumi,T Matsushima,A Yamane,N Doki,H Irisawa,T Saitoh,T Sakura,T Jimbo,H Handa,N Tsukamoto,M Karasawa,S Miyawaki,H Murakami,Y Nojima,

For similar diagnosis: prognosis: treatment outcome research abstracts see: diagnosis: prognosis: treatment outcome research

PUBMED ID PMID:

MEDLINE DATE:

Prevalence and clinical characteristics of acute myeloid leukemia associated with disseminated intravascular coagulation. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: International journal of hematology

VOLUME: 86

Page Numbers: 137-42

Journal Abbreviation: Int. J. Hematol.

ISSN: 0925-5710

DAY: 30

MONTH: Aug

YEAR: 2007

Prevalence and clinical characteristics of acute myeloid leukemia associated with disseminated intravascular coagulation. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9111627

Prevalence and clinical characteristics of acute myeloid leukemia associated with disseminated intravascular coagulation. Keywords Mesh Terms:

KEYWORDS: Treatment Outcome

MESH TERMS: complications

Chemical & Substance for Abstract: Prevalence and clinical characteristics of acute myeloid leukemia associated with disseminated intravascular coagulation. Information

Substance Name: Antigens, CD13

Registry Number: EC 3.4.11.2

Grant and Affiliation Information for Prevalence and clinical characteristics of acute myeloid leukemia associated with disseminated intravascular coagulation.

AFFILIATION: Department of Medicine and Clinical Science, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan. huchiumi@med.gunma-u.ac.jp

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Int J Hematol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Prevalence and clinical characteristics of acute myeloid leukemia associated with disseminated intravascular coagulation Related Publications

• Activation of histamine secretion from rat mast cells by phosphatidylserine analogues resistant to phospholipase A action.
• Angiotensin II provokes podocyte injury in murine model of HIV-associated nephropathy.
• C-Reactive protein induced agglutination of lipid suspensions prepared in the presence and absence of phosphatidylcholine.
• Cross-talks between transcription and post-transcriptional events within a 'mRNA factory'.
• Detergent-resistant phospholipase A1 and A2 in Escherichia coli.
• Effect of albumin and methylated albumin on the glucose permeability of lipid membranes.
• Effect of temperature on hemolysis of human erythrocytes induced by dilauroyllecithin.
• Immune reactions of liposomes containing cardiolipin and their relation to membrane fluidity.
• Immunohistochemical localization of bone morphogenetic protein-2 in the oral and maxillofacial area of the human embryo.
• Mcp4, a meiotic coiled-coil protein, plays a role in F-actin positioning during Schizosaccharomyces pombe meiosis.
• Morphology of lipid micelles containing lysolecithin.
• Nature of Escherichia coli mutants deficient in detergent-resistant and/or detergent-sensitive phospholipase A.
• Partial purification and properties of phospholipase A2 from rat liver mitochondria.
• Phospholipase A of Mycobacterium phlei: a regulatory membrane enzyme with ferric iron as effector.
• Phospholipid patterns in subcellular fractions of Mycobacterium phlei.
• Physical properties and barrier functions of synthetic glyceroglycolipids.
• Positional distribution of fatty acids in phospholipids from Mycobacteria.
• Positional specificity of phospholipase B of Penicillium notatum.
• Prevalence and clinical characteristics of acute myeloid leukemia associated with disseminated intravascular coagulation.
• Properties of liposomal membranes composed of short-chain lecithins.
• Properties of liposomal membranes containing lysolecithin.
• Properties of purified detergent-resistant phospholipase A of Escherichia coli K-12. Inactivation, and protection with detergents and phospholipids.
• Reactivity of human C-reactive protein with positively charged liposomes.
• Release of vesicles containing acetylcholinesterase from erythrocyte membranes by treatment with dilauroylglycerophosphocholine.
• Studies on the metabolism of phospholipids in Mycobacterium phlei. I. Difference in turnover rates of individual phospholipids.
• Synthesis of various phospholipids from 2-acyl lysophospholipids by Escherichia coli extract.
• Transacylation between diacylphospholipids and 2-acyl lysophospholipids catalyzed by Escherichia coli extract.
• Transfer of cholestane spin label between lipid bilayer membranes and its molecular motion in membranes.
• [Pseudo-thrombocytopenia with uncountable platelets complicated by retroperitoneal fibrosis and bleeding symptoms]
• [Renal disease in multiple myeloma]